Rosenblatt Securities Reaffirms "Buy" Rating for Arteris (NASDAQ:AIP)

Key Points

• Rosenblatt Securities reaffirmed its Buy rating on Arteris with a $38 price target, implying about 20% upside; analysts overall assign the stock a “Moderate Buy” rating with an average target of $38.50.
• Arteris beat quarterly revenue expectations with $24.13 million, but its $0.10 per-share loss was wider than the consensus $0.04 loss. Analysts expect a full-year loss of approximately $0.58 per share.
• Insiders have sold heavily, including the CEO, with 1.5 million shares worth $52.2 million sold over the past three months; insiders still own 23.3% of the company, while institutions and hedge funds own 64.36%.

Arteris (NASDAQ:AIP - Get Free Report)'s stock had its "buy" rating reiterated by research analysts at Rosenblatt Securities in a report issued on Friday,Benzinga reports. They presently have a $38.00 target price on the stock. Rosenblatt Securities' price objective suggests a potential upside of 20.18% from the stock's previous close.

A number of other brokerages also recently issued reports on AIP. Oppenheimer began coverage on Arteris in a report on Thursday, July 16th. They issued an "outperform" rating and a $40.00 price target for the company. TD Cowen raised their price objective on shares of Arteris from $22.00 to $40.00 and gave the stock a "buy" rating in a report on Wednesday, May 13th. Weiss Ratings downgraded shares of Arteris from a "sell (d-)" rating to a "sell (e+)" rating in a research report on Wednesday, May 13th. Northland Securities set a $38.00 target price on shares of Arteris in a report on Wednesday, May 13th. Finally, Wall Street Zen downgraded shares of Arteris from a "buy" rating to a "hold" rating in a research report on Saturday, May 2nd. Four research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $38.50.

Arteris Stock Performance

Shares of AIP stock opened at $31.62 on Friday. The company has a market cap of $1.46 billion, a P/E ratio of -40.03 and a beta of 1.96. The firm has a fifty day moving average price of $36.06 and a 200 day moving average price of $26.16. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.17. Arteris has a 12 month low of $8.42 and a 12 month high of $50.26.

Arteris (NASDAQ:AIP - Get Free Report) last posted its quarterly earnings results on Thursday, August 6th. The company reported ($0.10) earnings per share for the quarter, missing analysts' consensus estimates of ($0.04) by ($0.06). The business had revenue of $24.13 million during the quarter, compared to the consensus estimate of $23.48 million. Sell-side analysts predict that Arteris will post -0.58 earnings per share for the current fiscal year.

Insider Transactions at Arteris

In other news, CEO K Charles Janac sold 26,106 shares of the stock in a transaction that occurred on Tuesday, August 4th. The stock was sold at an average price of $31.97, for a total value of $834,608.82. Following the completion of the sale, the chief executive officer directly owned 8,329,071 shares of the company's stock, valued at approximately $266,280,399.87. This represents a 0.31% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, major shareholder Bayview Legacy, Llc sold 26,106 shares of the firm's stock in a transaction that occurred on Tuesday, August 4th. The stock was sold at an average price of $31.97, for a total transaction of $834,608.82. Following the transaction, the insider owned 8,329,071 shares in the company, valued at approximately $266,280,399.87. This trade represents a 0.31% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 1,498,949 shares of company stock worth $52,200,293 in the last three months. Corporate insiders own 23.30% of the company's stock.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the business. Versant Capital Management Inc boosted its holdings in shares of Arteris by 33.7% in the second quarter. Versant Capital Management Inc now owns 1,150 shares of the company's stock valued at $56,000 after acquiring an additional 290 shares in the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. acquired a new stake in Arteris in the second quarter valued at about $53,000. Intech Investment Management LLC boosted its holdings in Arteris by 9.3% in the 4th quarter. Intech Investment Management LLC now owns 13,540 shares of the company's stock valued at $210,000 after purchasing an additional 1,148 shares in the last quarter. Deutsche Bank AG increased its position in Arteris by 7.7% during the 4th quarter. Deutsche Bank AG now owns 21,159 shares of the company's stock worth $328,000 after purchasing an additional 1,504 shares during the period. Finally, BNP Paribas Financial Markets raised its stake in shares of Arteris by 75.0% during the 3rd quarter. BNP Paribas Financial Markets now owns 6,053 shares of the company's stock worth $61,000 after buying an additional 2,595 shares in the last quarter. 64.36% of the stock is currently owned by institutional investors and hedge funds.

More Arteris News

Here are the key news stories impacting Arteris this week:

• Positive Sentiment: Arteris reported second-quarter revenue of $24.13 million, above the $23.48 million analyst consensus. Management also forecast third-quarter revenue of $24 million to $25 million and full-year revenue of $95 million to $98 million, both ahead of consensus estimates. The improved revenue outlook supports the growth case for Arteris’ semiconductor interconnect and system-IP business. Arteris second-quarter results and guidance
• Positive Sentiment: Roth Capital initiated coverage with a Buy rating and a $40 price target. The recommendation adds to recent bullish analyst coverage, including Oppenheimer’s Outperform rating, and indicates potential upside from recent trading levels. Roth Capital Buy rating
• Neutral Sentiment: Arteris appointed Saurabh Sinha as chief financial officer and chief accounting officer, effective September 8, 2026. The leadership change may improve financial oversight, although investors will likely await further details on his priorities and transition. Arteris CFO appointment
• Negative Sentiment: Second-quarter adjusted loss was $0.10 per share, worse than the $0.04–$0.05 consensus loss and only modestly improved from the $0.11 loss a year earlier. The earnings shortfall is the main reason the results could weigh on the stock despite the revenue beat. Arteris second-quarter earnings report
• Negative Sentiment: Insiders reported a cluster of sales, including CEO K. Charles Janac’s sales, Director Saiyed Atiq Raza’s sale of 70,000 shares, and Vice President Paul Alpern’s sale of 4,000 shares. Although insiders retain substantial holdings, the transactions may create a cautious sentiment around AIP. Arteris insider selling

Arteris Company Profile

Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company's core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.

Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source